Mangoceuticals, Inc.
MGRX
$0.34
$0.000.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.15% | -281.06% | -126.51% | -104.40% | 24.13% |
| Total Depreciation and Amortization | -37.92% | 185.52% | 2,472.92% | 6,593.55% | 11,357.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.91% | 1,014.67% | 267.69% | 337.81% | -36.77% |
| Change in Net Operating Assets | 2,076.16% | -5,090.32% | 130.46% | -82.51% | -12.60% |
| Cash from Operations | 4.59% | -6.48% | 20.34% | -129.52% | 33.46% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 300.00% | -- | 500.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 191.45% | -- | 345.74% | 530.56% | -36.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.61% | 116.21% | -35.58% | 754.21% | -6.46% |
| Foreign Exchange rate Adjustments | 91.46% | 100.00% | 118.18% | 7,700.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6,669.28% | 191.35% | -94.84% | 102.46% | 96.93% |